Should investors buy Reckitt shares today?

Reckitt shares have outperformed the FTSE 100 by a wide margin over the long term. Edward Sheldon looks at whether they’re worth buying today.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Risk reward ratio / risk management concept

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Reckitt (LSE: RKT) shares have been an excellent long-term investment. Over the last 20 years, they’ve risen about six-fold and provided a steady stream of dividends along the way.

Are they worth buying today? Let’s discuss.

Long-term growth potential?

Let’s start with growth potential. Can the company – which operates in the areas of health, hygiene, and nutrition – grow its revenues and profits in the years ahead?

The answer to this question is yes, in my view.

Between now and 2028, the global consumer health market is projected to grow by around 7-8% per year. This market growth should provide healthy tailwinds for Reckitt, which owns some of the biggest brands in the industry (Dettol, Nurofen, Durex, Strepsils, etc).

Nutrition is another area that has plenty of potential. Reckitt owns one of the biggest brands in the infant formula space (Enfamil). And the market for these products is projected to grow by around 10% a year over the next decade.

One thing Reckitt has going for it on the growth front is brand power. This gives it the ability to raise its prices. This is handy in an inflationary environment.

Another thing it has going for it is the fact that consumers tend to purchase its products no matter what’s happening in the global economy. This is valuable in an environment of economic uncertainty, like we’re experiencing now.

In light of all this, I think the company is well-placed to generate solid growth in the years ahead.
It’s worth noting that currently, City analysts expect revenue of £14.96bn this year and £15.61bn next year, up from £14.45bn in 2022. Net profit is expected to climb to £2,451m in 2023 and £2,645m in 2024, up from £2,330m in 2022.

This top- and bottom-line growth is expected to support higher dividends. I’ll point out that Reckitt recently raised its annual payout by 5% to 183.3p per share (a yield of around 3%) and said it’s aiming to deliver sustainable dividend growth in future years.


What about the valuation though? Do the shares offer value right now?

Well, at present, Reckitt is expected to generate earnings per share of £3.40 this year. This means at the current share price, the forward-looking price-to-earnings (P/E) ratio is about 18.

That is higher than the market average (the median P/E ratio across the FTSE is about 14). But I don’t think it’s an excessive valuation, given Reckitt’s track record of success.

Interestingly, analysts at Berenberg recently raised their target price for the shares to 7,575p. That’s nearly 25% above the current share price.


As for risks here, there are a few that are worth mentioning. Competition from new brands is one. These days, it’s easier for new brands to capture market share due to the power of social media.

Changing consumer preferences is another. There’s no guarantee that Reckitt’s brands will remain popular going forward.

A new CEO (Nicandro Durante) is also a risk. Durante previously worked in the tobacco industry and doesn’t appear to have much experience in health, hygiene, or nutrition.

My view

Overall though, I have a positive view on the shares at present. I think they’re worth buying today.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has positions in Reckitt Benckiser Group Plc. The Motley Fool UK has recommended Reckitt Benckiser Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Turning a £20k ISA into a stunning £38,023 a year passive income

Harvey Jones says investing regular sums in a Stocks and Shares ISA is a brilliant way of building up a…

Read more »

Growth Shares

Growth stock YouGov just fell 46%. Time to buy?

YouGov’s share price just fell from 820p to 440p after a poor trading update. Is now a good time to…

Read more »

Investing Articles

2 mouthwatering FTSE growth stocks I’d buy and hold for 10 years

Growth stocks purchased today could be the gateway to many years of capital growth and returns. Here are two picks…

Read more »

Investing Articles

Can the IAG share price really be as dirt cheap as it looks?

While most shares have recovered since the Covid days, the IAG share price is staying stuck to rock bottom. Surely…

Read more »

Investing Articles

BAE Systems shares are flying! Have I missed the boat?

Sumayya Mansoor looks into whether or not BAE Systems shares are still a good buy for her portfolio after the…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

1 heavyweight FTSE 100 share I’d buy as London retakes its crown

Some Footsie firms are extremely large, but that doesn't mean they couldn't get even bigger. Here's one such FTSE 100…

Read more »

Investing Articles

I’d buy 5,127 National Grid shares to generate £250 of monthly passive income

With a dividend yield of 6.5%, Muhammad Cheema takes a look at how National Grid shares can generate a healthy…

Read more »

Investing Articles

The FTSE 100’s newest member looks like a no-brainer to me!

This Fool explains why she sees the newest member of the FTSE 100 as a great opportunity after its recent…

Read more »